Therapeutic potential of neuregulin-1 in cardiovascular disease

Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/91713

Full metadata record

DC Field	Value	Language
dc.creator	Pedro Mendes Ferreira
dc.creator	Gilles W De Keulenaer
dc.creator	Adelino F Leite Moreira
dc.creator	Carmen Bras Silva
dc.date.accessioned	2022-09-09T00:10:24Z	-
dc.date.available	2022-09-09T00:10:24Z	-
dc.date.issued	2013
dc.identifier.issn	1359-6446
dc.identifier.other	sigarra:47937
dc.identifier.uri	https://hdl.handle.net/10216/91713	-
dc.description.abstract	Neuregulin-1 (NRG-1)/ErbB signaling has an indispensable role in cardiac development and in the maintenance of the structural and functional integrity of the human adult heart in health and disease. Several animal studies have now demonstrated the therapeutic effects of NRG-1 during acute cardiac injury and during chronic heart failure, with improvements in cardiac performance and animal survival. Phase I and II clinical trials for chronic heart failure in humans are now in progress.
dc.language.iso	eng
dc.rights	restrictedAccess
dc.subject	Ciências da Saúde, Medicina básica
dc.subject	Health sciences, Basic medicine
dc.title	Therapeutic potential of neuregulin-1 in cardiovascular disease
dc.type	Outra Publicação em Revista Científica Internacional
dc.contributor.uporto	Faculdade de Medicina
dc.identifier.doi	10.1016/j.drudis.2013.01.010
dc.identifier.authenticus	P-006-7HV
dc.subject.fos	Ciências médicas e da saúde::Medicina básica
dc.subject.fos	Medical and Health sciences::Basic medicine
Appears in Collections:	FMUP - Outra Publicação em Revista Científica Internacional

Files in This Item:

File	Description	Size	Format
47937.pdf Restricted Access		443.59 kB	Adobe PDF	View/Open